The END Fund announces innovative new initiative to accelerate progress towards elimination of intestinal worms and promote better health

The END Fund announces innovative new initiative to accelerate progress towards elimination of intestinal worms and promote better health

Share on facebook
Facebook
Share on twitter
Twitter
Share on linkedin
LinkedIn
Share on email
Email
Share on print
Print

Initiative will:

  • Leverage the donation of 50 million doses of an essential medicine to at-risk young children and adults in sub-Saharan Africa, where the burden of intestinal worms is high 
  • Unlock match funding from private philanthropists, enabling greater investments in capacity building and health systems strengthening
  • Ensure sustainable on-the-ground efforts toward promoting “health for all”

KIGALI, RWANDA, 2 February, 2021, -/African Media Agency (AMA)/- Today, the END Fund is pleased to announce a new opportunity to fast-track progress against intestinal worms among school children and other at-risk groups in Ethiopia, Kenya, and Rwanda. This announcement follows Johnson & Johnson’s commitment to donate 50 million doses of VERMOXÂź Chewable (mebendazole 500mg) to the World Health Organization (WHO) for at-risk populations, including children and women of reproductive age. Through its Deworming Innovation Fund (DIF) – an unprecedented initiative that accelerates progress towards eliminating disease caused by parasitic worms – the END Fund will leverage this drug donation to mobilize additional philanthropic capital and coordinate with governments and partners to create robust delivery systems.

Pic Credit: The END Fund / Mo Scarpell

The additional funding from DIF will result in a greater investment in the future of millions of children and adults. Funds saved on drug purchasing will be repurposed to support treatment delivery or other complementary interventions pending planning with national programs. This will result in more sustainable on-the-ground efforts to improve the quality of life for millions of people and will lead to improvements in the overall health and well-being of communities.

An estimated 1.5 billion people globally, predominantly in resource-limited settings, are infected with soil-transmitted helminths (STH), or intestinal worms, and require periodic treatment to prevent or control infection. The effects of intestinal worms on infected populations include malnutrition, anemia, stunting, impaired intellectual development, and susceptibility to other infectious diseases.

“Johnson & Johnson’s donation will improve the lives of millions and fast-track progress towards the elimination of disease caused by parasites that have held back human progress for millennia,” said Ellen Agler, CEO of the END Fund. “The Deworming Innovation Fund offers a unique platform for visionary donors to come together and support the ambitious goals of our government partners, and we are thrilled that Johnson & Johnson is building on its incredible track record to help demonstrate that it is possible to end these diseases in our lifetimes, on our watch.”

Pic Credit: The END Fund / Gabriel Dusabe

Since the London Declaration on Neglected Tropical Diseases (NTDs) in 2012, there have been significant commitments for drug donations to increase treatments for NTDs. As part of its long-standing commitment to tackle NTDs, Johnson & Johnson has delivered more than 1.7 billion doses of VERMOXŸ since 2006. Notably, the introduction of VERMOXŸ Chewable, a new formulation of mebendazole, allows for easier administration to children, as it can be easily chewed or mixed with a small amount of water to form a soft mass that is swallowed by children as young as one year of age.

“Intestinal worms prevent too many around the world from reaching their full potential – with the debilitating symptoms forcing children to stay home from school and adults from work,” said Martin Fitchet, M.D., Global Head, Global Public Health, Johnson & Johnson. “At Johnson & Johnson, we believe that all people, no matter where they live, should have the opportunity to thrive – and that’s why we are committed to doing our part to ensure that treatment for intestinal worms reaches those in need.”

Intestinal worms are one of many NTDs – a group of debilitating diseases that affect more than 1.7 billion people worldwide, with 40% of the burden in Africa alone. In line with interim guidance from the WHO, key parts of NTD programs – such as community and school mass drug administrations, training for health care workers, and community-based surveys – were all temporarily halted in April 2020 in response to the COVID-19 pandemic. Missing treatment cycles put the NTD community at significant risk of wiping away gains that took years to achieve. In July, 2020, the WHO released guidelines for how organizations could safely restart their programs while minimizing risk to health workers and community members. Following the WHO’s recent launch of an ambitious roadmap to end NTDs by 2030, it is more important now than ever to continue investing in this area to drive greater impact and reduce the burden caused by intestinal worms.

Distributed by African Media Agency (AMA) on behalf of the END Fund

About the END Fund

The END Fund is the only private philanthropic initiative solely dedicated to ending the five most common neglected tropical diseases (NTDs), which affect more than 1.7 billion people globally. It efficiently puts private capital to work, advocating for NTD programs that are innovative, integrated, and cost-effective. It facilitates strong partnerships with the private sector and has supported national disease control programs in 31 countries.

Since its founding in 2012, with its partners, the END Fund has provided over 920 million donated treatments worth over $1 billion, over 17,000 surgeries for people suffering from the effects of the advanced stages of elephantiasis and trachoma, and trained more than 2.7 million people in NTD control and elimination efforts. Visit www.end.org for more information.

About the Deworming Innovation Fund

Slated to run through 2025, the Deworming Innovation Fund accelerates progress towards tackling parasitic worm infections that affect more than 40 million people in Ethiopia, Rwanda, Zimbabwe, and Kenya. The END Fund will leverage drug donations from key pharmaceutical companies, and support and coordinate with governments and partners to create robust delivery systems. Over the next five years, people at risk of intestinal worms and schistosomiasis in these four strategic countries will benefit from increased access to deworming treatment which will improve overall health and wellbeing.

You might also enjoy

Subscribe To Our Newsletter

Get updates and learn from the best

Conférence de Presse en Ligne


Les frontiĂšres terrestres ne doivent pas constituer des obstacles Ă  la dissĂ©mination de votre message. GrĂące Ă  notre service de confĂ©rence de presse en ligne, nous vous offrons l’opportunitĂ© de vous rapprocher des mĂ©dias africains, chaque fois que vous en aurez besoin.​

Nos services comprennent:​

​

​

Digital Communications


Today, social networks constitute an organization’s first point of contact with a user and a potential customer. At first glance, you need to convince of the relevance and quality of your content to stimulate and motivate the user to go further. We create consistently inspiring online strategy to meet business objectives, engage stakeholders and enhance our client brand’s reputation internally and externally.​

 

Communication​ digitale


Les rĂ©seaux sociaux reprĂ©sentent aujourd’hui le premier point de contact d’une organisation avec un utilisateur et un client potentiel. Au premier coup d’Ɠil, vous devez le convaincre de la pertinence et de la qualitĂ© de votre contenu pour l’inciter Ă  aller plus loin. Nous crĂ©ons pour vous une stratĂ©gie de communication prĂ©cise et adaptĂ©e sur les rĂ©seaux sociaux pour atteindre les objectifs commerciaux, impliquer les parties prenantes et amĂ©liorer la rĂ©putation de votre marque en interne et en externe.​

Promotion​ d’Ă©vĂ©nements


Le succĂšs d’un Ă©vĂ©nement rĂ©side en moitiĂ© dans sa promotion. Peu importe la beautĂ© de l’évĂ©nement, la qualitĂ© des orateurs et de l’ordre du jour, si personne ne rapporte ou ne parle de votre Ă©vĂ©nement, vos efforts seront vains. Nous vous aidons Ă  façonner votre rĂ©cit et Ă  crĂ©er un engouement autour de votre Ă©vĂ©nement. De l’annonce de l’Ă©vĂ©nement Ă  la tenue de celui-ci, nous accompagnons votre effort de planification et le reflĂ©tons sur toutes les plateformes mĂ©diatiques.​

Formation​ MĂ©diatique


Nous fournissons Ă  vos porte-paroles les outils nĂ©cessaires pour prĂ©senter vos principaux messages et rĂ©pondre avec confiance et cohĂ©rence aux questions. Notre formation est organisĂ©e soit Ă  distance ou en prĂ©sentiel, avec des Ă©tudes de cas rĂ©els et des rĂ©pĂ©titions. Nos clients repartent avec le sentiment d’ĂȘtre Ă  l’aise devant les journalistes et d’agir en tant qu’ambassadeurs de la marque.​

Veille​ MĂ©diatique


Nous mesurons votre portĂ©e en relations publiques et rendons compte des informations de votre industrie et des activitĂ©s de vos  concurrents en surveillant la majoritĂ© des canaux de diffusion dans toute l’Afrique. Une veille mĂ©diatique complĂšte et opportune est essentielle pour s’assurer que vous ne manquez aucune rĂ©fĂ©rence Ă  votre marque, que vous ĂȘtes constamment informĂ© de ce qui se passe dans votre industrie et que vous ĂȘtes prĂȘt Ă  saisir les opportunitĂ©s et Ă  rĂ©duire les risques en temps opportun.​

Relations​ MĂ©dia


Peu importe le lieu oĂč ils se trouvent, nous sommes une source d‘informations fiables pour les journalistes qui Ă©crivent sur l’Afrique. Nous nous connaissons mutuellement et ils nous font confiance, car nous leur fournissons un contenu crĂ©dible qui les aide dans leurs tĂąches. Nous nous entretenons quotidiennement avec des journalistes aux quatre coins du continent, ce qui fait de nous l’un des organismes les plus efficaces pour mener des campagnes de relations avec les mĂ©dias.

Stratégie et développement de contenu


Nous crĂ©ons des stratĂ©gies de communication intelligentes, bien documentĂ©es et spĂ©cialisĂ©es destinĂ©es Ă  vous aider Ă  construire un rĂ©cit fort qui engagera votre audience. Nous travaillons en synergie avec vous afin de rĂ©diger des communiquĂ©s de presse et des articles d’opinions qui alimentent le rĂ©cit de votre entreprise. Notre Ă©quipe a une expĂ©rience approfondie dans la crĂ©ation de rĂ©cits et le dĂ©veloppement de contenu multimĂ©dia.

DIFFUSION DE COMMUNIQUES​ DE PRESSE​


C’est le service phare d’AMA. Nous avons mis en place des canaux de diffusion des communiquĂ©s de presse auprĂšs des journalistes des 54 États africains ainsi qu’auprĂšs des journalistes amĂ©ricains et europĂ©ens couvrant les sujets relatifs aux marchĂ©s Ă©mergents.​

​Nos services comprennent:​

​

​

Event Promotion


Half of the success of an event lays in its promotion. Doesn’t matter how beautiful the event is, how wonderful the speakers and the agenda are, if no one reports or talks about your event, your efforts are gone. We help you shape the narrative and create a drumbeat around your event. From the announce all the way to the outcome of the event, we accompany your planning effort and echo it through all media platforms

Media Training


We provide your spokespeople with the tools to present your key messages and answer questions with confidence and coherence. Our training is organised either remotely or face-to- face, with real case studies and rehearsals. Our clients leave feeling comfortable being in front of reporters and acting as brand ambassadors.

Media Monitoring


We measure and report on
your PR reach, industry news, and competitive activity by monitoring most channels in North, West, Central, East and Southern Africa. Comprehensive and timely media monitoring is critical to ensuring that you don’t miss any reporting of your brand,
you’re constantly informed on what’s going on around your business, and you’re ready to capitalise on opportunities and mitigate
risks in a timely fashion..

Media Relations


We have become an authoritative source of news for reporters writing about Africa, wherever they are. We know them, they know us, and they trust us for providing them with timely and accurate content that helps them do their job. We speak to reporters on a daily basis in all corners of the continent and this makes us one of the most effective agencies in running media relations campaigns.

Strategy & Content Development


We create smart and localised communications strategies to help build a strong narrative that will engage your audiences. We partner with you to create press releases and thought leadership pieces that sustain a drumbeat for your company’s narrative. Our team have deep experience in shaping narratives and developing media content.

PRESS RELEASE WIRE DISTRIBUTION

This is AMA’s flagship service. We have set up channels of distribution towards the journalists of the 54 African states, as well as to American journalists and European journalists covering emerging markets issues.
Our service includes:

Editorial advice

Localised editorial piece when needed

Distribution to the major print, broadcast and online publications along with industry-specific publications

Follow-up calls to secure interview request

Guaranteed distribution to Africa.com

Distribution to Bloomberg, LexisNexis and Thomson Reuters

Social Media Reach: Facebook, Twitter, LinkedIn, Instagram

Full online monitoring and print monitoring when available. Includesreadership stats and Advertising Value Equivalent

Translation in French, Arabic and Portuguese available